Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Hepatitis C and steatosis.

Anouk Dev¹, Keyur Patel, John G McHutchison

¹Duke Clinical Research Institute and Division of Gastroenterology, Duke University Medical Centre, P.O. Box 17969, Durham, NC 27715, USA.

Clinics in Liver Disease

|October 7, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Psychosocial impact of false-positive surveillance for hepatocellular carcinoma: a qualitative study.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026

Same author

Zoledronic acid improves bone mineral density at the lumbar spine and total hip in adults with chronic liver disease.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2026

Same author

Australian best practice recommendations for transjugular intrahepatic portosystemic shunt (TIPS) in portal hypertension: a consensus statement.

Hepatology international·2026

Same author

Drug-Induced Liver Injury Associated with Turmeric and Piperine: A Case and Review.

Case reports in gastroenterology·2025

Same author

Initial Trans-Arterial Chemo-Embolisation (TACE) Is Associated with Similar Survival Outcomes as Compared to Upfront Percutaneous Ablation Allowing for Follow-Up Treatment in Those with Single Hepatocellular Carcinoma (HCC) ≤ 3 cm: Results of a Real-World Propensity-Matched Multi-Centre Australian Cohort Study.

Cancers·2024

Same author

A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (SOCRATES HCC).

BMC cancer·2024

Steatosis, or fatty liver, is common in chronic hepatitis C (CHC) due to the hepatitis C virus (HCV) and metabolic factors. Understanding these interactions is key for developing targeted CHC therapies.

Area of Science:

Hepatology
Virology
Metabolic disease

Background:

Steatosis is frequently observed in patients with chronic hepatitis C (CHC).
Hepatitis C virus (HCV) has a direct steatogenic effect, and metabolic risk factors are common in the HCV population.
Steatosis is recognized as a risk factor for CHC disease progression and affects treatment outcomes.

Purpose of the Study:

To highlight the significance of steatosis in chronic hepatitis C.
To underscore the need for research into the pathogenesis of HCV-related steatosis.
To emphasize the goal of developing targeted therapeutic strategies.

Main Methods:

This abstract is a review of current understanding and does not detail specific experimental methods.
It synthesizes existing knowledge on viral and host factors contributing to steatosis in CHC.

Related Experiment Videos

Focuses on the clinical implications and future research directions.

Main Results:

Steatosis is a multifactorial condition in CHC, influenced by both the virus and host metabolic status.
Steatosis negatively impacts disease progression and response to therapy in CHC patients.
The complex interplay between HCV and host factors in steatosis pathogenesis requires further elucidation.

Conclusions:

Further research is essential to unravel the intricate viral and host interactions in HCV-related steatosis.
A deeper understanding will enable the development of precise and effective future therapeutic strategies for CHC.
Targeting the mechanisms of steatosis could improve treatment outcomes for chronic hepatitis C.